IndusLaw Advises Quantiphi
INDUSLAW Team comprised Aakash Dasgputa (Partner), Tushar Gogi (Principal Associate), Ravishankar M. (Senior Associate) with strategic inputs from Kartik Ganapathy (Founding Partner)
IndusLaw advised Quantiphi, in relation to its strategic minority investment in Tran-Scell Biologics Private Limited, marking a milestone in AI-supported drug discovery in the life sciences industry.
INDUSLAW Team comprised Aakash Dasgputa (Partner), Tushar Gogi (Principal Associate), Ravishankar M. (Senior Associate) with strategic inputs from Kartik Ganapathy (Founding Partner).
_20240916104607_original_image_20.webp)